GKOS
Glaukos Corporation · Healthcare
Chief Development Officer Tomas Navratil sold $100K of Glaukos Corporation
Sold$99,567
$139.06Price
716Shares
−1%Stake
What GKOS did after the filing
- The stock from Thu, Jul 9 open, $153.29
- +20.6%
- S&P 500, same days
- +2.5%
Measured over 30 trading days, to the Aug 21 close.
Traded Wed, Jul 1. Filed Wed, Jul 8, 8:53 PM ET, after the close. Returns use the Jul 9 open and the Aug 21 close. Not investment advice.